Concert Pharmaceuticals Inc. Company Name:
CNCE Stock Symbol:
NASDAQ Market:
Concert Pharmaceuticals Inc. Website:
News, Short Squeeze, Breakout and More Instantly...
Image source: The Motley Fool. Concert Pharmaceuticals, Inc. (NASDAQ: CNCE) Q3 2020 Earnings Call Nov 6, 2020 , 8:30 p.m. ET Operator Continue reading For further details see: Concert Pharmaceuticals, Inc. (CNCE) Q3 2020 Earnings Call Tra...
CTP-543 THRIVE-AA1 Phase 3 Trial Initiated in Patients with Moderate to Severe Alopecia Areata CTP-543 Treatment Shows Maintenance of Hair Regrowth in Open Label Extension Trial; Data Presented at EADV Virtual Meeting CTP-692 Phase 2 Trial Fully Enrolled; Top...
Concert Pharmaceuticals, Inc. (NASDAQ: CNCE) today announced it has initiated THRIVE-AA1, the first Phase 3 clinical trial to evaluate the efficacy and safety of CTP-543, an oral Janus kinase inhibitor, in adult patients with moderate to severe alopecia areata. The Company expects t...